Hudson, MA, United States of America

Erik Meredith

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Cambridge, MA (US) (2012 - 2013)
  • Hudson, MA (US) (2012 - 2020)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovative Mind of Erik Meredith

Introduction

Erik Meredith, an esteemed inventor based in Hudson, MA, has made significant contributions to the field of pharmaceuticals and medicinal chemistry. With an impressive portfolio of 18 patents, he stands out as a prominent figure in innovation, particularly within Novartis AG, a leading global healthcare company dedicated to the development of advanced medicines.

Latest Patents

Erik's latest patents showcase his creativity and commitment to improving health outcomes. One such patent involves Hydroquinazoline derivatives for the treatment of diseases or disorders. This disclosure relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof, which encompasses specific substitutions as described in the documentation. This innovation includes compositions and methods for utilizing these compounds effectively.

Another notable patent from Erik involves indane and indoline derivatives that act as soluble guanylate cyclase activators. This patent presents a compound of formula (I), alongside a method for manufacturing these compounds and detailing their therapeutic uses. Furthermore, it offers combinations of pharmacologically active agents and pharmaceutical compositions aimed at enhancing patient care.

Career Highlights

Throughout his career, Erik has continuously pushed the boundaries of innovation in pharmacology. His extensive research and development efforts have not only led to valuable patents but have also contributed to advancements in treatments for various diseases. His role at Novartis AG has placed him at the forefront of medical discovery, fostering an environment of collaborative invention.

Collaborations

Erik has collaborated with esteemed coworkers such as Nan Ji and James J Powers, who share his passion for research and innovation. This teamwork has enabled the exploration of new ideas and methodologies within the pharmaceutical landscape, all aimed at creating effective treatment solutions.

Conclusion

In summary, Erik Meredith exemplifies the spirit of innovation with his 18 patents and ongoing contributions to the pharmaceutical field. His focus on developing unique compounds and therapeutic uses illustrates his dedication to enhancing healthcare. With a robust career at Novartis AG, Erik continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…